Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 9 studies | 39% ± 20% | |
| neuron | 5 studies | 29% ± 11% | |
| GABAergic neuron | 5 studies | 44% ± 15% | |
| retinal ganglion cell | 4 studies | 73% ± 25% | |
| interneuron | 3 studies | 41% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 32% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 94% | 8351.10 | 2483 / 2642 | 83% | 41.16 | 586 / 705 |
| ovary | 42% | 497.75 | 76 / 180 | 57% | 2.70 | 245 / 430 |
| adrenal gland | 9% | 97.52 | 22 / 258 | 74% | 31.00 | 171 / 230 |
| eye | 0% | 0 | 0 / 0 | 61% | 3.88 | 49 / 80 |
| pancreas | 0% | 0 | 0 / 328 | 38% | 2.87 | 68 / 178 |
| uterus | 1% | 7.37 | 2 / 170 | 34% | 2.73 | 155 / 459 |
| lung | 0% | 0 | 0 / 578 | 35% | 2.35 | 401 / 1155 |
| breast | 2% | 12.67 | 7 / 459 | 32% | 1.84 | 353 / 1118 |
| spleen | 28% | 209.77 | 68 / 241 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 27% | 1.36 | 242 / 901 |
| stomach | 1% | 8.57 | 5 / 359 | 23% | 1.46 | 67 / 286 |
| skin | 0% | 2.94 | 8 / 1809 | 24% | 1.89 | 114 / 472 |
| bladder | 0% | 0 | 0 / 21 | 22% | 1.62 | 110 / 504 |
| liver | 0% | 0 | 0 / 226 | 20% | 2.58 | 82 / 406 |
| prostate | 0% | 2.29 | 1 / 245 | 19% | 0.83 | 95 / 502 |
| esophagus | 1% | 5.47 | 13 / 1445 | 18% | 1.23 | 33 / 183 |
| intestine | 7% | 51.41 | 71 / 966 | 12% | 0.68 | 61 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.69 | 7 / 45 |
| thymus | 0% | 0 | 0 / 653 | 14% | 1.28 | 83 / 605 |
| adipose | 1% | 6.30 | 8 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 1.95 | 3 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0140059 | Biological process | dendrite arborization |
| GO_0051923 | Biological process | sulfation |
| GO_0008202 | Biological process | steroid metabolic process |
| GO_0008150 | Biological process | biological_process |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0008146 | Molecular function | sulfotransferase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SULT4A1 |
| Protein name | Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST) Sulfotransferase family 4A member 1 |
| Synonyms | SULTX3 |
| Description | FUNCTION: Atypical sulfotransferase family member with very low affinity for 3'-phospho-5'-adenylyl sulfate (PAPS) and very low catalytic activity towards L-triiodothyronine, thyroxine, estrone, p-nitrophenol, 2-naphthylamine, and 2-beta-naphthol. May have a role in the metabolism of drugs and neurotransmitters in the CNS. . |
| Accessions | ENST00000432404.5 Q9BR01 F8WE22 ENST00000330884.9 [Q9BR01-1] ENST00000422525.1 [Q9BR01-2] |
